Generation of a homozygous CRISPR/Cas9-mediated knockout H9 hESC subline for the CRB1 locus

Xiangcheng Tang1, Zhigang Chen1, Xuhua Tan1

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.

Stem Cell Research
|October 31, 2020
PubMed

Insights

CRB1 gene mutations cause early-onset retinitis pigmentosa (RP). Researchers created CRB1-knockout human embryonic stem cells to study RP mechanisms, finding they retain normal stem cell properties.

Area of Science:

  • Genetics and Stem Cell Biology
  • Ophthalmology and Vision Science

Background:

  • Mutations in the CRB1 gene are linked to early-onset autosomal recessive retinitis pigmentosa (RP), a condition causing severe vision loss.
  • Understanding the molecular mechanisms underlying CRB1-related RP is crucial for developing potential therapeutic strategies.

Purpose of the Study:

  • To investigate the pathogenic mechanisms of CRB1-knockout (CRB1-/-) induced RP.
  • To generate and characterize a human embryonic stem cell (hESC) model for studying CRB1-related retinal degeneration.

Main Methods:

  • Generation of a H9 hESC subline with homozygous frame shift mutations in exon 2 of the CRB1 gene.
  • Assessment of pluripotency markers, karyotype stability, and differentiation potential into all three germ layers (endoderm, mesoderm, ectoderm).

Main Results:

  • The generated CRB1-/- hESC subline successfully expressed key pluripotent stem cell markers.
  • The cells maintained a normal karyotype, indicating genomic stability.
  • The CRB1-/- hESCs demonstrated the capacity to differentiate into endodermal, mesodermal, and ectodermal lineages, similar to wild-type cells.

Conclusions:

  • The developed CRB1-/- hESC line serves as a valuable in vitro model for studying the pathogenesis of CRB1-associated RP.
  • Despite the CRB1 gene mutation, the hESC subline retains essential stem cell characteristics, facilitating further research into retinal cell development and disease mechanisms.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.1K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.7K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
60.5K